{"id":3886,"date":"2026-05-07T07:59:11","date_gmt":"2026-05-07T07:59:11","guid":{"rendered":"https:\/\/echeloncreativemedia.com\/marketvows\/2026\/05\/07\/morgan-stanleys-top-stock-picks-as-earnings-season-winds-down\/"},"modified":"2026-05-07T07:59:11","modified_gmt":"2026-05-07T07:59:11","slug":"morgan-stanleys-top-stock-picks-as-earnings-season-winds-down","status":"publish","type":"post","link":"https:\/\/echeloncreativemedia.com\/marketvows\/2026\/05\/07\/morgan-stanleys-top-stock-picks-as-earnings-season-winds-down\/","title":{"rendered":"Morgan Stanley’s Top Stock Picks as Earnings Season Winds Down"},"content":{"rendered":"

As first-quarter earnings season winds down, Morgan Stanley is highlighting specific stocks with strong potential for post-report gains. The bank has identified a basket of companies rated ‘overweight’ that are expected to report soon and score highly on their ‘Earnings Surprise Composite’.<\/p>\n

Key picks include Ulta Beauty, Target, and Applied Materials, with analysts pointing to strategic investments, positive sentiment, and a history of strong performance as drivers for future growth.<\/p>\n

<\/p>\n

READ MORE FROM CNBC<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

As first-quarter earnings season winds down, Morgan Stanley is highlighting specific stocks with strong potential for post-report gains. The bank has identified a basket of companies rated ‘overweight’ that are expected to report soon and score highly on their ‘Earnings Surprise Composite’. Key picks include Ulta Beauty, Target, and Applied Materials, with analysts pointing to […]<\/p>\n","protected":false},"author":1,"featured_media":3887,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/image.cnbcfm.com\/api\/v1\/image\/108300717-1777652502485-gettyimages-2273425807-SEAPORT_THERAPEUTICS_IPO.jpeg?v=1777652610&w=600&h=300&vtcrop=y","fifu_image_alt":"","footnotes":""},"categories":[28,31],"tags":[],"class_list":["post-3886","post","type-post","status-publish","format-standard","has-post-thumbnail","category-economy","category-technology","rifnote_executive-lorraine-hutchinson","rifnote_executive-paul-lejuez","rifnote_executive-shane-brett"],"fifu_image_url":"https:\/\/image.cnbcfm.com\/api\/v1\/image\/108300717-1777652502485-gettyimages-2273425807-SEAPORT_THERAPEUTICS_IPO.jpeg?v=1777652610&w=600&h=300&vtcrop=y","_links":{"self":[{"href":"https:\/\/echeloncreativemedia.com\/marketvows\/wp-json\/wp\/v2\/posts\/3886","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/echeloncreativemedia.com\/marketvows\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/echeloncreativemedia.com\/marketvows\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/echeloncreativemedia.com\/marketvows\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/echeloncreativemedia.com\/marketvows\/wp-json\/wp\/v2\/comments?post=3886"}],"version-history":[{"count":0,"href":"https:\/\/echeloncreativemedia.com\/marketvows\/wp-json\/wp\/v2\/posts\/3886\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/echeloncreativemedia.com\/marketvows\/wp-json\/wp\/v2\/media\/3887"}],"wp:attachment":[{"href":"https:\/\/echeloncreativemedia.com\/marketvows\/wp-json\/wp\/v2\/media?parent=3886"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/echeloncreativemedia.com\/marketvows\/wp-json\/wp\/v2\/categories?post=3886"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/echeloncreativemedia.com\/marketvows\/wp-json\/wp\/v2\/tags?post=3886"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}